Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;43(2):82-86.
doi: 10.1136/medethics-2015-103116. Epub 2016 Jun 3.

When to start paediatric testing of the adult HIV cure research agenda?

When to start paediatric testing of the adult HIV cure research agenda?

Seema K Shah. J Med Ethics. 2017 Feb.

Abstract

Ethical guidelines recommend that experimental interventions should be tested in adults first before they are tested and approved in children. Some challenge this paradigm, however, and recommend initiating paediatric testing after preliminary safety testing in adults in certain cases. For instance, commentators have argued for accelerated testing of HIV vaccines in children. Additionally, HIV cure research on the use of very early therapy (VET) in infants, prompted in part by the Mississippi baby case, is one example of a strategy that is currently being tested in infants before it has been well tested in adults. Because infants' immune systems are still developing, the timing of HIV transmission is easier to identify in infants than in adults, and infants who receive VET might never develop the viral reservoirs that make HIV so difficult to eradicate, infants may be uniquely situated to achieve HIV cure or sustained viral remission. Several commentators have now argued for earlier initiation of HIV cure interventions other than (or in addition to) VET in children. HIV cure research is therefore a good case for re-examining the important question of when to initiate paediatric research. I will argue that, despite the potential for HIV cure research to benefit children and the scientific value of involving children in this research, the HIV cure agenda should not accelerate the involvement of children for the following reasons: HIV cure research is highly speculative, risky, aimed at combination approaches and does not compare favourably with the available alternatives. I conclude by drawing general implications for the initiation of paediatric testing, including that interventions that have to be used in combination with others and cures for chronic diseases may not be valuable enough to justify early paediatric testing.

Keywords: Ethics; HIV Infection and AIDS; Newborns and Minors; Paediatrics; Research Ethics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Cited by

References

    1. Purcell DF, Elliott JH, Ross AL, et al. . Towards an HIV cure: Science and debate from the International AIDS Society 2013 symposium. Retrovirology 2013;10:134 10.1186/1742-4690-10-134 - DOI - PMC - PubMed
    1. Eyal N, Kuritzkes DR. Challenges in clinical trial design for HIV-1 cure research. Lancet 2013;382:1464–5. 10.1016/S0140-6736(13)62040-1 - DOI - PubMed
    1. Persaud D, Gay H, Ziemniak C, et al. . Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med 2013;369:1828–35. 10.1056/NEJMoa1302976 - DOI - PMC - PubMed
    1. Luzuriaga K, Gay H, Ziemniak C, et al. . Viremic relapse after HIV-1 remission in a perinatally infected child. N Engl J Med 2015;372:786–8. 10.1056/NEJMc1413931 - DOI - PMC - PubMed
    1. Shah SK, Persaud D, Wendler DS, et al. . Research into a functional cure for HIV in neonates: the need for ethical foresight, Lancet Infect Dis 2014;14:893–8. 10.1016/S1473-3099(14)70766-2 - DOI - PMC - PubMed

Publication types

LinkOut - more resources